Anxieties About Moving Amid Cardiac Concerns
I'm a 20-year-old who has been dealing with constant mild symptoms that are somewhat vague for nearly five months. Coupled with my background of severe anxiety, I often experience a range of symptoms without warning. What truly frightens me is that I consistently feel a little unwell whenever I engage in any physical activities. Whenever I stand or move around, I tend to feel at least slightly lightheaded or dizzy. Generally, it feels more like my body is weak and light rather than on the verge of fainting. I should note that the only times I've experienced true presyncope involved getting my blood drawn or, once as a child, during a gym class in hot weather. In addition to that, I frequently notice odd symptoms. Sometimes, these are chest-related, like mild tightness—usually on the left side—feelings of fullness, or even slight soreness. Other times, I encounter more random sensations, such as pressure in my ears or head, distorted vision (though I don’t have blurred vision or loss of sight, leading me to believe dissociation might be influencing this), or a sensation that my breathing feels tight, even though I’m not gasping for air—just discomfort. I’ve considered the possibility of Postural Orthostatic Tachycardia Syndrome (POTS), as my heart rate sometimes spikes significantly—over 40 beats per minute—just from standing up, although there are days when this doesn’t occur. Symptoms vary day-to-day but tend to be milder during the evenings. I recognize that I have become deconditioned, but despite not being very active even before my symptoms worsened, I had managed some exercise. A few weeks ago, I attempted a ten-minute workout designed for seniors, but it left me extremely sore and raised my heart rate to 190 bpm. Nowadays, my physical activity mainly consists of walking around my home and yard for a few minutes a few times daily, very light yoga, meal preparation, and basic hygiene routines. As someone who is also recovering from agoraphobia, my outings have been limited to scheduled exposures. Tomorrow, I'm scheduled to move, and I can’t shake the fear that the stress of the process will land me in the hospital. A couple of weeks ago, I started doing light packing for about 30 to 60 minutes a day, but I always felt fatigued enough to stop well before finishing and often experienced the aforementioned chest discomfort. For instance, on one occasion, I had fleeting chest pains along with the typical tightness, whereas on another day, I noticed dull aching in the left side of my chest. Nearly every time I experience chest discomfort, it sends me into a panic. Additionally, I frequently feel some form of air hunger or labored breathing, although my oxygen saturation levels are consistently normal. This leads me to wonder if my struggles with breath are simply perceived. Although the tightness does vary, it's generally not severe or unbearable—merely a troubling annoyance that sparks concern due to its location. I suspect my anxiety about packing has exacerbated my symptoms in recent months. Now that the majority of packing is done, I feel like I’m in a peaceful phase before a chaotic transition. While I’ve been moving less, the chest tightness appears to be more constant, sometimes reflecting as a dull pressure or tension. My fatigue and feelings of dissociation have notably intensified. Occasionally, the discomfort is triggered by movement, but it also appears without warning. There were days where a tight fullness gripped my left chest for an hour or two before fading away. Over the last few months, I have had "flare-ups" of both chest discomfort and fatigue that seem to worsen for periods before subsiding, though other symptoms may arise. Each day, I grow increasingly aware of how even the simplest tasks feel daunting due to these troubling sensations. Just yesterday, even taking out the trash or playing the piano triggered symptoms. In recent days, my chest discomfort has lingered for most of the day. I am in the process of selecting a new primary care physician, as my previous one has closed their practice, but it will likely be weeks before I can secure an appointment—definitely not in time for the move. Recently, I had a telehealth consultation and blood tests, which failed to provide me with any solid reassurance, the results showing only minor abnormalities. Hence, I remain uncertain whether my issues are indeed related to my heart, a concern that has persisted for some time. Two years ago, I underwent both an EKG and a Holter monitor, which returned normal results; however, I believe those tests may not have ruled out all potential issues, so I plan to request a referral for another cardiologist once I establish care with a new PCP. I’m unsure how to proceed. I do not want to feel completely helpless on moving day, but even if this is just a result of my anxiety, I know I will struggle to assist while worrying about my well-being. I have also been contemplating a visit to urgent care prior to the move; however, I'm uncertain what they would do beyond an EKG and possibly more blood tests, and many concerns still wouldn't be addressed. I definitely want to avoid an emergency room visit on moving day. If the move were not looming, I would likely opt to wait for a PCP appointment, but I'm feeling desperate to make it through the day in one piece.
Answers (1)
8/2/2025, 6:10:58 AM
OpenHealth AI
It's understandable to feel anxious about moving, especially with the symptoms you've described. Your concerns about lightheadedness, chest discomfort, and overall fatigue could be driven both by your physical state and anxiety. While it's crucial to address your underlying symptoms, focusing on practical steps to manage your situation on moving day is important.
Main Points:
- Your symptoms may have both physical and anxiety-related components.
- Planning for the move can help alleviate some anxiety.
- Prioritize light activity and self-care to ease physical discomfort.
Explanation:
The symptoms you’re experiencing, such as lightheadedness when standing, mild chest tightness, and a heightened heart rate with exertion, can be interconnected and influenced by anxiety and possible deconditioning. It's great that you recognize the impact of anxiety on your physical sensations — this awareness can be a tool in managing them. Your experiences of dizziness and lightheadedness, especially when engaging in physical activities, could indicate a condition like POTS, but lifestyle and anxiety management will be essential as you prepare for your move.
Next Steps:
-
Prioritize Self-Care:
- Stay hydrated and eat something light before engaging in any activity, as low blood sugar can increase fatigue and discomfort.
- Plan to take breaks during the moving process. Pace yourself and avoid lifting anything too heavy or engaging in strenuous activities.
-
Practice Breathing Techniques:
- When you feel anxious or experience sensations of discomfort, practice deep breathing: inhale slowly through your nose for 4 seconds, hold for 4 seconds, then exhale through your mouth for 4 seconds. This can help calm both your mind and your body. Repeat this several times, especially if you start feeling overwhelmed.
-
Communicate Your Needs:
- If possible, share your concerns with friends or family helping on moving day. Let them know you may need to take breaks or step away for a moment if you feel overwhelmed or fatigued.
-
Avoid Overexertion:
- If you feel unwell when moving, stop and rest until your symptoms improve. Don't hesitate to sit down or change your activity level based on how you're feeling.
-
Post-Move Plan:
- Once settled, prioritize finding a new primary care physician. Discuss your history and any ongoing concerns, including possibly revisiting testing for heart-related issues if symptoms persist.
If symptoms significantly worsen or you experience severe discomfort, consider visiting urgent care for reassurance. Remember that listening to your body is vital, and you may need to prioritize your well-being during this transition. Take care and approach the move with patience for yourself.
Related Questions
Understanding Atrial Fibrillation and Thyroid Issues: Variability in Cardioversion Decisions
Hello everyone, I’m reaching out for guidance regarding my mother’s current health situation, and I’d greatly appreciate any shared experiences or thoughts. **My mother's background:** - **Age**: 55 years - **Weight**: Recently dropped to 116 kg from 118 kg in just two days, likely due to diuretics. - **Health history**: Previously an underactive thyroid, undiagnosed and untreated, now presenting as overactive. - **Medications**: Currently taking thyroid medication and a beta-blocker (Rapiblock). **Current health status:** My mother has been hospitalized since Tuesday, experiencing **atrial fibrillation with heart rates exceeding 200** beats per minute due to her thyroid's hyperactivity. - The plan for cardioversion was initially settled on Tuesday. However, the following day, the medical team advised postponing it until her thyroid levels could be stabilized, believing that her heart rate would return to normal once her thyroid condition was managed. - Her **obesity** precludes her from undergoing a transthoracic echocardiogram, and due to her thyroid concerns, she cannot handle contrast dye (this has been a consistent issue for over four years). Therefore, the only feasible option was a **transesophageal echocardiogram (TEE)**, which has yet to be performed. - She has been prescribed various medications including beta-blockers and thyroid treatments in the past. - On Friday, a doctor proposed proceeding with cardioversion; however, the attending senior physician objected. - Today (Saturday), another clinician has expressed a desire to move forward with cardioversion, having initiated a new medication, as the senior physician is unavailable. - **Communication has been unclear**, as we were notified of developments by a nurse rather than the physician in charge, causing confusion and anxiety. - Currently, only a **chest X-ray** is scheduled, and the TEE remains unaddressed. **My inquiries are as follows:** 1. Is it common for medical professionals to have varying opinions and frequently revise medication or treatment plans like cardioversion? 2. Is it safe to conduct cardioversion in the absence of a TEE? I presumed that this was a standard procedure to exclude the presence of blood clots. 3. Is it usual practice to have only a chest X-ray prior to moving ahead with cardioversion? 4. How typical is it for patients or their families to not be directly informed about treatment changes and learn about them through nursing staff instead? I recognize that this cannot substitute for professional medical advice. I’m simply trying to discern whether these circumstances are typical or if we should express our concerns more assertively with the healthcare facility. Thank you for your insights!
28-Year-Old Male Experiencing Scalp Sensations Post-Amitriptyline Treatment
I am a 28-year-old man in generally good health, without any cardiac concerns. Approximately a month ago, I encountered intense pain localized to one side of my head, which was unresponsive to paracetamol. However, a single dose of a migraine treatment provided substantial relief. Following that, I began a regimen of amitriptyline, starting at a nightly dose of 10 to 25 mg. While my head pain has diminished significantly—by about 90 to 95%—I now experience occasional uncomfortable sensations on my scalp. These feelings include pins and needles, a cooling sensation, and some crawling feelings near my hairline and ears. There are fleeting moments where I feel brief throbs lasting a second, but I do not have any persistent headaches. To clarify, I do not experience any of the following: - Nausea - Weakness in my limbs - Numbness - Changes in my vision - Coordination difficulties - Seizures The symptoms I have are transient, shifting around and often intensifying when I become conscious of them or as the day progresses. I would like to know: Is it common to experience these sensations during the recovery stage following episodes of neuralgia or migraine-like discomfort? Additionally, could the amitriptyline potentially be causing these temporary paresthetic sensations? I am seeking some reassurance or advice on what is typically observed during this healing process. Thank you.
Concerns About My Toes
Age: 30, Female Currently, I am on the lookout for a reputable podiatrist in my vicinity. However, I've encountered a perplexing issue with my foot. Just last night, I noticed a growth on the side of my toe, something entirely new to me. I maintain a nutritious diet and have a demanding job that requires me to be on my feet quite often. My footwear includes brands such as Brooks Ghost Runners, Hoka Bondi 9’s, and Nike Motiva’s, and I don’t opt for restrictive socks. I also apply Vick’s Vaporub to my feet, a practice handed down from my family, and stick with simple, non-fragrant lotions like Vanicream and CeraVe SA Cream for my skin. In addition, I am curious about the my big toenail's change in color. What might be the underlying reasons for this? Also, I have these persistent dark spots on my toes that I've struggled with since my days on the runway. Despite my efforts, nothing has succeeded in lightening or diminishing their appearance. I'm just looking to determine if there might have been a factor from the past that could have contributed to these issues. I’m not sure what else to include, but I’m open to answering any questions you might have. Thank you for your attention! Best wishes from a worried soul!
7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options
# 7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options ## [7-Month-Old] Identified with Abernethy Malformation (Congenital Portosystemic Shunt) - Treatment Methods? **Age:** 7 months **Gender:** Female **Height:** Age-appropriate **Weight:** Currently 9 kg, was 2.8 kg at birth **Ethnicity:** Asian **Duration of Symptoms:** Present since birth **Location:** Uzbekistan **Pre-existing Health Issues:** Abernethy malformation (congenital portosystemic shunt), liver hemangiomas, chronic jaundice, anemia **Current Treatments:** Supportive management --- ## INITIAL PRESENTATION (June 2025 - July 2025) Our daughter arrived on **June 27, 2025**, presenting with: - Birth weight: **2.8 kg** - Marked jaundice (yellowing of skin and sclera) - Pale or clay-colored stools - **Bilirubin level: 245 μmol/L** (typically <20) An immediate ultrasound indicated multiple liver anomalies, initially thought to be hemangiomas. --- ## FIRST COMPREHENSIVE ASSESSMENT (August 1, 2025 - 1 Month Old) ### Multislice Computed Tomography (MSCT) with 3-Phase Contrast (August 1, 2025): **RESULTS:** - **Portocaval shunt size: 9.9 mm** (blood bypassing the liver into the inferior vena cava) - **Arteriovenous shunt size: 4.4 mm** - **Portal vein size: 6.1 mm** (patent) - **Three nodular cystic lesions** located in the perivascular area, with largest measuring 11.6×20.7 mm, enhancing during the venous phase - Liver features a heterogeneous architecture, exhibiting irregular enhancement - Gallbladder appears elongated and slightly enlarged - Other abdominal organs exhibit normal findings **RADIOLOGIST’S ASSESSMENT:** "Congenital portosystemic shunt indicative of Abernethy malformation; less likely arteriovenous malformation (AVM); cannot dismiss the possibility of localized liver lesions." **ADVICE:** Seek consultations with an abdominal and vascular surgeon. ### Blood Tests (August 1, 2025): **Complete Blood Count:** - WBC: 10.44 × 10⁹/L (normal range) - **RBC: 2.1 × 10¹²/L** (LOW - indicating severe anemia) - **Hemoglobin: 69 g/L** (CRITICALLY LOW; normal is 117-166) - Platelets: 403 × 10⁹/L (elevated) **Biochemistry Analysis:** - Urea: 1.80 mmol/L (normal) - Creatinine: 33.4 μmol/L (normal) - **ALT: >1000 IU/mL** (EXTREMELY HIGH - severe liver dysfunction) --- ## FOLLOW-UP IMAGING (December 16, 2025 - 5.5 Months Old) ### Liver Ultrasound: **RESULTS:** - Right lobe: 64 mm, left lobe: 43 mm - Liver capsule appears irregular and vague - **Parenchyma: heterogeneous, showing 7 hypo-isoechoic nodules** (sizes range from 11.5×10.7 mm to 17.6×15.4 mm) - Capsule features uneven contours - Blood flow noted during Doppler examination - No dilation in intrahepatic bile ducts - **Portal vein: 3.9 mm** (decreased from 6.1 mm - indicating improvement) - Common bile duct: 1.4 mm - Gallbladder: measures 43.7×9.2 mm (pear-shaped, wall thickness 2.0 mm, homogeneous, free of stones) **ULTRASOUND ASSESSMENT:** "Presence of liver volumetric formations (specifically liver hemangiomas)." --- ## LATEST MSCT (February 6, 2026 - 7 Months Old) ### MSCT with 3-Phase Contrast: **FINDINGS:** - Liver remains normal in size, but shows heterogeneous structure with uneven contrast enhancement - **Portocaval shunt: 9.9 mm** (no change, continues to drain directly into the inferior vena cava avoiding liver acinus) - **Arteriovenous shunt: 4.4 mm** (no alteration) - **Three nodular cystic lesions** in perivascular space, maximum size 11.6×20.7 mm, enhancing in the venous phase - **Portal vein: 6.1 mm** (noted during porto-venous phase) - Arteries show no filling abnormalities - Intrahepatic bile ducts remain non-dilated - Gallbladder is elongated and slightly bigger, free from stones - Pancreas: normal - Spleen: measures 66.9×38.5 mm (not enlarged), splenic vein is 3.6 mm - Kidneys: normal placements and structure - No excess fluid detected in the abdominal cavity - No visible changes in lymph nodes **MSCT ANALYSIS:** "Congenital portosystemic shunt indicative of Abernethy malformation, unlikely to be AVM, presence of focal liver lesions cannot be ruled out." **RECOMMENDATION:** Engage with an abdominal and vascular surgeon. --- ## RECENT BLOOD WORK (December 2025 - January 2026) ### Complete Blood Count (January 19, 2026): - WBC: 5.8 × 10⁹/L (SHOWS IMPROVEMENT) - **RBC: 2.93 × 10¹²/L** (IMPROVED but still low) - **Hemoglobin: 72 g/L** (SHOWS IMPROVEMENT but still low) - Platelets: 223 × 10⁹/L (BACK TO NORMAL) - Neutrophils: 30.0% - Lymphocytes: 64.8% - Monocytes: 4.6% ### Biochemistry (January 28, 2026): - Total protein level: 67 g/L (slightly deficient) - Creatinine: 20.7 μmol/L - **Total Bilirubin: 242 μmol/L** (STILL HIGH - unchanged) - **Direct Bilirubin: 142 μmol/L** (VERY HIGH) - **ALT: 50 IU/mL** (DRASTICALLY LOWER from >1000!) --- ## OVERVIEW OF PROGRESS OVER 6 MONTHS | Parameter | August 2025 | January 2026 | Change | |------------------|-------------|---------------|--------------------------| | **Hemoglobin** | 69 g/L | 72 g/L | ↗ Slight improvement | | **RBC** | 2.1 | 2.93 | ↗ Improved | | **ALT** | >1000 | 50 | ✓✓ MAJOR IMPROVEMENT | | **Bilirubin** | 245 | 242 | → Unchanged (still elevated) | | **Portal vein** | 6.1 mm | 3.9 mm (US) | ↗ Decreased | | **Platelets** | 403 | 223 | ↘ Normalized | | **Shunt size** | 9.9 mm | 9.9 mm | → No Change | --- ## CURRENT SITUATION (February 2026 - 7 Months Old) - **Weight:** 9 kg (good growth rate in spite of condition) - **Jaundice:** Continues to be present (yellow skin) - **Stools:** Remain pale/clay-colored - **Development:** Achieving appropriate milestones - **Energy:** Appears to have a good energy level - **Feeding:** Normal appetite --- ## QUESTIONS FOR r/AskDocs We have been informed this is **Type 2 Abernethy malformation** (portal vein present). **Three treatment avenues have been proposed:** ### Option 1: **Endovascular Coil Embolization** (minimally invasive approach) - A catheter is inserted via the leg vein to access the shunt and deploy coils/plugs to close the abnormal vessels - Pros: No surgical incision, minimal discomfort, short hospital stay (2-4 days), no scars, enhanced safety - Duration: 1-2 hours - Recovery: 2-4 weeks for jaundice to show improvement ### Option 2: **Open Surgical Intervention** - An incision in the abdomen to ligate abnormal vessels and redirect blood to the liver - Pros: Direct visualization, effective results - Cons: Surgical scar, longer recovery time (7-14 days in hospital) - Duration: 2-4 hours ### Option 3: **Liver Transplantation** - We have been advised this is not necessary as the portal vein is functional and liver health is improving. --- ## SPECIFIC QUESTIONS TO CONSIDER: 1. **With a functional portal vein (6.1 mm) and improving liver function (ALT normalized), is it advisable to pursue endovascular closure as the preferred treatment?** 2. **Despite ALT levels improving, the bilirubin remains consistently high (242). Should this be a cause for concern? Is there a prospect for it to normalize post shunt closure?** 3. **Are the hemangiomas/nodules (11.6×20.7 mm) linked to the shunt? Will they likely resolve following shunt repair?** 4. **How urgent is the proposed intervention? Is immediate action required, or is there flexibility to wait a few months?** 5. **What complications should we be vigilant for during the waiting period?** 6. **Regarding endovascular closure - what is the average success rate for infants aged 7 months? Are there concerns regarding the shunt size (9.9 mm)?** 7. **The measurement of the portal vein has shown improvement from 6.1 mm to 3.9 mm; should this be perceived as a positive sign or a reason for concern?** 8. **Are there special directives (diet modifications, medications) we should consider while awaiting the procedure?** 9. **Post-procedure, how long should we expect it might take for:** - Normalization of bilirubin levels? - Return of stool color to normal? - Resolution of jaundice? - Regression of hemangiomas? 10. **Can you recommend any specialized centers for pediatric Abernethy malformation treatments? We are located in Uzbekistan but are prepared to travel (to Turkey, Russia, South Korea, etc.)** --- ## ADDITIONAL INFORMATION - No family history of hepatic diseases - Pregnancy and delivery were normal - No additional congenital defects identified - Immunizations up to date - No history of bleeding disorders - No signs indicative of encephalopathy - Child is alert and engaged --- **I can supply actual MSCT images and comprehensive lab reports if they would be of assistance.** We sincerely appreciate any insights you can provide. We are striving to make the most informed decision regarding our daughter’s care and highly value expert medical opinions. **TL;DR:** 7-month-old diagnosed with Abernethy Type 2 malformation (9.9 mm portocaval shunt, patent portal vein). Liver functionality is improving (normalized ALT) while bilirubin remains elevated (242). Evaluating options between endovascular coil embolization and open surgery. Seeking expert advice on optimal treatment strategy and timing.
Strange Jelly-Like Substance Observed from Wound
I’m a 21-year-old female living with an auto-inflammatory condition known as hidradenitis suppurativa (HS). Recently, I've experienced a concerning issue with one of my wounds. This particular wound causes significant pain and excessive bleeding. However, whenever I attend to it, I tend to find this unusual jelly-like substance present within it. Interestingly, this phenomenon has only occurred with this one wound and not any of the others I have. The bleeding seems to persist until I manage to remove this jelly substance, after which it typically slows down and comes to a halt completely. I’m seeking insights into what this might signify so that I can effectively discuss it with my healthcare provider.